Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Aerosol Liposomal Cyclosporine for BOS
NCT01650545Phase 2Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- Jul 2012
- Primary completion
- Aug 2015
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclosporine in Bronchiolitis Obliterans Syndrome (BOS), sponsored by University of Maryland, Baltimore. Started Jul 2012; status: completed.
02
Drugs
cyclosporine
03
Conditions
Bronchiolitis Obliterans Syndrome (BOS)
Beyond the preview
Go deeper on NCT01650545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01650545.